BSX vs. LIF

Last updated Jun 13, 2026

BSX (Boston Scientific Corporation) and LIF (Life360, Inc.) are both stocks. BSX operates in Medical Devices (Healthcare), while LIF operates in Software - Application (Technology). Over the past year, BSX returned -52.97% vs -25.93% for LIF. At a 0.25 correlation, their price movements are largely independent.

Performance

BSX vs. LIF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Scientific Corporation (BSX) and Life360, Inc. (LIF). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BSX achieves a -50.80% return, which is significantly lower than LIF's -29.45% return.

BSX

• 1D: -0.55%
• 1M: -10.95%
• YTD: -50.80%
• 6M: -49.33%
• 1Y: -52.97%
• 3Y*: -2.85%
• 5Y*: 1.80%
• 10Y*: 7.42%

LIF

• 1D: -0.07%
• 1M: 17.44%
• YTD: -29.45%
• 6M: -33.03%
• 1Y: -25.93%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BSX vs. LIF - Yearly Performance Comparison

	2026 (YTD)	2025	2024
BSX Boston Scientific Corporation	-50.80%	6.75%	17.70%
LIF Life360, Inc.	-29.45%	55.42%	58.73%

Correlation

The correlation between BSX and LIF is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (All Time) Calculated using the full available price history since Jun 6, 2024	0.25

The correlation between BSX and LIF shifts across timeframes, from 0.14 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap BSX : $70.13B LIF : $3.88B
EPS BSX : $2.38 LIF : $1.75
PE Ratio BSX : 19.74 LIF : 25.86
PS Ratio BSX : 3.40 LIF : 7.30
PB Ratio BSX : 2.71 LIF : 6.49
Total Revenue (TTM) BSX : $20.62B LIF : $528.98M
Gross Profit (TTM) BSX : $14.52B LIF : $407.86M
EBITDA (TTM) BSX : $4.76B LIF : $26.53M

Return for Risk

BSX vs. LIF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSX

BSX Risk / Return Rank: 2
BSX Sharpe Ratio Rank: 0
BSX Sortino Ratio Rank: 2
BSX Omega Ratio Rank: 1
BSX Calmar Ratio Rank: 5
BSX Martin Ratio Rank: 1

LIF

LIF Risk / Return Rank: 27
LIF Sharpe Ratio Rank: 24
LIF Sortino Ratio Rank: 27
LIF Omega Ratio Rank: 26
LIF Calmar Ratio Rank: 28
LIF Martin Ratio Rank: 30

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BSX vs. LIF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and Life360, Inc. (LIF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BSX	LIF	Difference
Sharpe ratio: Return per unit of total volatility	-1.51	-0.43	-1.09
Sortino ratio: Return per unit of downside risk	-2.27	-0.23	-2.04
Omega ratio: Gain probability vs. loss probability	0.67	0.97	-0.30
Calmar ratio: Return relative to maximum drawdown	-0.93	-0.43	-0.49
Martin ratio: Return relative to average drawdown	-2.00	-0.70	-1.30

BSX vs. LIF - Sharpe Ratio Comparison

The current BSX Sharpe Ratio is -1.51, which is lower than the LIF Sharpe Ratio of -0.43. The chart below compares the historical Sharpe Ratios of BSX and LIF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BSX vs. LIF - Drawdown Comparison

The maximum BSX drawdown since its inception was -89.15%, which is greater than LIF's maximum drawdown of -65.64%. Use the drawdown chart below to compare losses from any high point for BSX and LIF.

Drawdown Indicators

	BSX	LIF	Difference
Max Drawdown Largest peak-to-trough decline	-89.15%	-65.64%	-23.51%
Max Drawdown (1Y) Largest decline over 1 year	-56.62%	-65.64%	+9.02%
Max Drawdown (3Y) Largest decline over 3 years	-56.62%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-56.62%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-56.62%	—	—
Current Drawdown Current decline from peak	-56.62%	-59.19%	+2.57%
Average Drawdown Average peak-to-trough decline	-38.76%	-21.35%	-17.41%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.23%	40.82%	-14.59%

Volatility

BSX vs. LIF - Volatility Comparison

Boston Scientific Corporation (BSX) and Life360, Inc. (LIF) have volatilities of 15.84% and 16.67%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BSX	LIF	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.84%	16.67%	-0.83%
Volatility (6M) Calculated over the trailing 6-month period	32.83%	52.85%	-20.02%
Volatility (1Y) Calculated over the trailing 1-year period	34.77%	67.08%	-32.31%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	25.69%	62.97%	-37.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.29%	62.97%	-35.68%

Dividends

BSX vs. LIF - Dividend Comparison

Neither BSX nor LIF has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

BSX vs. LIF - Profitability Comparison

The chart below illustrates the profitability comparison between Boston Scientific Corporation and Life360, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.

LIF - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Life360, Inc. reported a gross profit of 110.56M and revenue of 143.12M. Therefore, the gross margin over that period was 77.3%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.

LIF - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Life360, Inc. reported an operating income of -8.08M and revenue of 143.12M, resulting in an operating margin of -5.6%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.

LIF - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Life360, Inc. reported a net income of 2.78M and revenue of 143.12M, resulting in a net margin of 1.9%.

Frequently Asked Questions

Can I hold both BSX and LIF in my portfolio?

BSX and LIF have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BSX or LIF?

LIF has higher volatility (16.67%) compared to BSX (15.84%). In terms of maximum drawdown, BSX dropped -89.15% vs LIF's -65.64%.

Which has better risk-adjusted returns?

LIF currently has the higher Sharpe Ratio (-0.43 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.